2-carboxamide cycloamino ureas useful as PI3K inhibitors

Details for Australian Patent Application No. 2010268058 (hide)

Owner Novartis AG

Inventors Fairhurst, Robin Alec; Gerspacher, Marc; Mah, Robert

Agent Davies Collison Cave

Pub. Number AU-A-2010268058

PCT Pub. Number WO2011/000855

Priority 61/270,028 02.07.09 US

Filing date 30 June 2010

Wipo publication date 6 January 2011

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 513/14 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2011/000855 Priority application(s): WO2011/000855

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010268065-Method for manufacturing a laminated glazing element

2010268045-A rainwater treatment unit